Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

May 19, 2021

5250_rns_2021-05-19_047be8e4-401f-4dc8-a015-111351ec20f1.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

FORM 8.3 - WILLIS TOWERS WATSON PLC

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 18 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,655,840 1.28% 172,212 0.13%
(2) Derivatives (other than options):
72,359 0.06% 0 0.00%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
(4) TOTAL:
1,734,299 1.34% 178,312 0.14%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 266.3300 USD
Purchase 1 264.0200 USD
Purchase 80 267.3200 USD
Purchase 100 267.2400 USD
Purchase 100 264.2200 USD
Purchase 104 266.9880 USD
Purchase 231 265.1755 USD
Purchase 248 267.7300 USD
Purchase 400 264.1450 USD
Purchase 476 263.6700 USD
Purchase 518 265.3950 USD
Purchase 600 264.0941 USD
Purchase 937 264.0546 USD
Purchase 1,319 264.3748 USD
Purchase 1,406 263.6732 USD
Purchase 1,780 266.2159 USD
Purchase 2,037 264.0921 USD
Purchase 2,068 267.0854 USD
Purchase 2,458 265.8989 USD
Purchase 2,679 266.5237 USD
Purchase 2,980 263.6726 USD
Purchase 3,126 264.3861 USD
Purchase 3,196 266.3756 USD
Purchase 4,595 267.0474 USD
Purchase 12,236 266.2871 USD
Purchase 12,633 264.3340 USD
Purchase 47,536 266.8931 USD
Sale 1 266.3300 USD
Sale 1 267.1600 USD
Sale 1 267.0100 USD
Sale 1 266.5400 USD
Sale 2 267.6500 USD
Sale 17 267.0900 USD
Sale 59 267.0506 USD
Sale 85 267.0600 USD
Sale 100 264.2200 USD
Sale 100 265.5240 USD
Sale 100 266.6700 USD
Sale 100 266.9800 USD
Sale 100 266.9900 USD
Sale 100 267.2100 USD
Sale 100 267.9400 USD
Sale 100 268.1900 USD
Sale 152 266.4007 USD
Sale 165 266.9000 USD
Sale 200 267.0150 USD
Sale 200 265.3750 USD
Sale 245 266.6166 USD
Sale 272 267.0257 USD
Sale 286 266.4767 USD
Sale 300 265.8466 USD
Sale 301 267.5095 USD
Sale 396 266.8227 USD
Sale 400 266.4090 USD
Sale 400 266.5000 USD
Sale 500 264.0690 USD
Sale 1,052 266.6726 USD
Sale 1,061 266.5752 USD
Sale 1,407 263.6734 USD
Sale 1,444 267.0759 USD
Sale 1,618 266.4900 USD
Sale 1,758 265.7810 USD
Sale 1,858 263.6718 USD
Sale 2,633 267.0890 USD
Sale 2,722 266.4493 USD
Sale 3,651 263.6700 USD
Sale 4,019 267.0042 USD
Sale 4,074 264.0921 USD
Sale 4,196 266.0480 USD
Sale 4,725 265.8693 USD
Sale 6,614 265.9435 USD
Sale 7,505 266.9606 USD
Sale 9,792 263.9634 USD
Sale 12,296 267.0175 USD
Sale 26,310 266.8060 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 19 May 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210519005481/en/

BARCLAYS PLC